Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer H Barrett

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
BMC Genetics|April 12, 2007
DNA repair gene XRCC1 polymorphisms and bladder cancer riskSei Chung Sak, Jennifer H Barrett, Alan B Paul, et al.
Plos One|January 5, 2012
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppressionNils Schoof, Mark M Iles, D Timothy Bishop, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
Comprehensive analysis of 22 XPC polymorphisms and bladder cancer riskSei Chung Sak, Jennifer H Barrett, Alan B Paul, et al.
Melanoma Research|May 20, 2016
Psychosocial, clinical and demographic features related to worry in patients with melanomaZoe Rogers, Faye Elliott, Nadine A Kasparian, et al.
Diabetes & Vascular Disease Research|November 25, 2005
RAGE polymorphisms and the heritability of insulin resistance: the Leeds family studyClair M Sullivan, T Simon Futers, Jennifer H Barrett, et al.
Rheumatology Advances in Practice|November 30, 2023
Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK BiobankCharikleia Chatzigeorgiou, John C Taylor, Faye Elliott, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 15, 2013
Do vitamin A serum levels moderate outcome or the protective effect of vitamin D on outcome from malignant melanoma?Sinead Field, Faye Elliott, Juliette Randerson-Moor, et al.
Clinical Chemistry|July 9, 2005
Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometryRosamonde E Banks, Anthea J Stanley, David A Cairns, et al.
Pharmacogenetics and Genomics|September 6, 2005
No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinomaLouise E McGreavey, Faye Turner, Gillian Smith, et al.
BMC Bioinformatics|December 6, 2008
Integrated multi-level quality control for proteomic profiling studies using mass spectrometryDavid A Cairns, David N Perkins, Anthea J Stanley, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
BMC Genetics|April 12, 2007
DNA repair gene XRCC1 polymorphisms and bladder cancer riskSei Chung Sak, Jennifer H Barrett, Alan B Paul, et al.
Plos One|January 5, 2012
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppressionNils Schoof, Mark M Iles, D Timothy Bishop, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
Comprehensive analysis of 22 XPC polymorphisms and bladder cancer riskSei Chung Sak, Jennifer H Barrett, Alan B Paul, et al.
Melanoma Research|May 20, 2016
Psychosocial, clinical and demographic features related to worry in patients with melanomaZoe Rogers, Faye Elliott, Nadine A Kasparian, et al.
Diabetes & Vascular Disease Research|November 25, 2005
RAGE polymorphisms and the heritability of insulin resistance: the Leeds family studyClair M Sullivan, T Simon Futers, Jennifer H Barrett, et al.
Rheumatology Advances in Practice|November 30, 2023
Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK BiobankCharikleia Chatzigeorgiou, John C Taylor, Faye Elliott, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 15, 2013
Do vitamin A serum levels moderate outcome or the protective effect of vitamin D on outcome from malignant melanoma?Sinead Field, Faye Elliott, Juliette Randerson-Moor, et al.
Clinical Chemistry|July 9, 2005
Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometryRosamonde E Banks, Anthea J Stanley, David A Cairns, et al.
Pharmacogenetics and Genomics|September 6, 2005
No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinomaLouise E McGreavey, Faye Turner, Gillian Smith, et al.
BMC Bioinformatics|December 6, 2008
Integrated multi-level quality control for proteomic profiling studies using mass spectrometryDavid A Cairns, David N Perkins, Anthea J Stanley, et al.
Pageof 13